M&A Deal Summary |
|
|---|---|
| Date | 2008-08-06 |
| Target | Eli Lilly & Co - Greenfield Laboratories |
| Sector | Test/Measurement Equipment |
| Buyer(s) | Covance |
| Sellers(s) | Lilly |
| Deal Type | Divestiture |
| Deal Value | 50M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Revenue | 2.6B USD (2013) |
Covance is a drug development company and a provider in nutritional analysis, is dedicated to advancing healthcare and delivering Solutions Made Real. Covance was founded in 1987 and is based in Princeton, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 5 |
| Sector (Test/Measurement Equipment) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Indiana) | 1 of 1 |
| Country (United States) | 2 of 4 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-11-27 |
Covance Cardiac Safety Services
Reno, Nevada, United States Covance Cardiac Safety Services, Inc. processes electrocardiograms in digital environment. |
Sell | $35M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-08-10 |
TRAC Microbiology
Madison, Wisconsin, United States TRAC Microbiology, Inc. is a food microbiology and chemistry laboratory. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1876 |
| Sector | Life Science |
| Employees | 43,000 |
| Revenue | 34.1B USD (2023) |
Lilly discovers, develops, manufactures, and markets products in two business segments—human pharmaceutical products and animal health products. The mission of its human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Most of the products Eli Lilly sells were discovered or developed by its own scientists, and the Company's success depends to a great extent on its ability to continue to discover, develop, and bring to market innovative new medicines. Eli Lilly's animal health business, operating through its Elanco division, develops, manufactures, and markets products for both food animals and companion animals. Eli Lilly manufactures and distributes its products through facilities in the US, Puerto Rico, and 11 other countries. Lilly was founded in 1876 and is based in Indianapolis, Indiana.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 9 |
| Sector (Test/Measurement Equipment) | 1 of 1 |
| Type (Divestiture) | 5 of 8 |
| State (Indiana) | 2 of 5 |
| Country (United States) | 6 of 9 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-07-08 |
SGX Pharmaceuticals
San Diego, California, United States SGX Pharmaceuticals, Inc., based in San Diego, California, is a biotechnology company focused on drug discovery and development in the area of oncology. |
Buy | $64M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-10-06 |
ImClone Systems
Bridgewater, New Jersey, United States ImClone Systems is a fully integrated biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. The company's research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone Systems' headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New Jersey. |
Buy | $6.5B |
